Last month, the Court of Arbitration for Sport (CAS) released a verdict that has become one of the most hotly debated rulings in sport history. At the centre of this decision is one woman: the South African mid-distance phenom Caster Semenya. Semenya has a condition called 46XY DSD, which results in her body producing higher than average levels of testosterone. The science and emotions behind this case are complex, and have divided the world of athletics in a way that is unprecedented. In this episode, 3 guests offer their unique perspectives on this complex topic. Amby Burfoot is the former Editor-in-Chief at Runner’s World Magazine. In Part 1, we chatted with Burfoot about his reasons for agreeing with testosterone limits. Today in Part 2, we talk with former track and field Olympian and professor Dr. Bruce Kidd. We also speak with Dr. Payoshni Mitra, who was instrumental in overturning the hyperandrogenism ruling in the 2015 Dutee Chand case. Dr. Kidd and Dr. Mitra share their reasons for disagreeing with the CAS ruling, and their hopes for the future. (To skip ahead to Part 2, go to 33:05)

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related